Jobless Claims, Q4 GDP Dip; Durable Goods Soar +3.4%

 | Feb 24, 2021 10:29PM ET

Thursday, February 25, 2021

New Initial Jobless Claims numbers are out this Thursday morning, as nearly every Thursday, with numbers far lower than expected and week over week: 730K new jobless claims were made last week, way down from the 845K projected. It’s also a whopping 111K lower than the previous month’s downwardly revised 841K. These are still historically high numbers overall, but toward the lower end of the current cycle, and a welcome sight.

Continuing Claims, reported for the prior week, came in at 4.42 million — a more than 100K drop from the upwardly revised 4.52 million the week previous. Unlike Initial Claims, which shows a rather volatile 12-week chart, Continuing Claims have generated a steady stream downward. Of course, much of this has to do with workers expiring on longer-term claims moving over to Pandemic Unemployment Assistance (PUA), which took in another million Americans two weeks ago.

One caveat to these weekly numbers was foreseen ahead of time by analysts: weather conditions in much of the country, especially in hard-hit Texas, look to have affected these figures to the downside temporarily. Thus, while we see relatively strong jobless claims numbers this week, we might expect either an upward revision next week, higher-than-normal headline numbers, or both. Currently, 19 million Americans claim some sort of unemployment insurance.

The first revision to Q4 Gross Domestic Product (GDP) was also released ahead of today’s opening bell, dipping 10 basis points to 4.1%. It was still a good effort to get the U.S. economy closer to breakeven after the disastrous Q2 — any quarter in a “normal year” would be pleased as punch to see 4%+ growth. Keep in mind this growth in the final quarter of last year was without the benefit of an additional stimulus package we saw that brought much of Q3 back from Q2.

Durable Goods Orders for January stormed past expectations this morning: +3.4% more than tripled the 1.0% analysts were looking for. This manufacturing metric also saw a big upward revision for December, from 0.5% originally reported to +1.2% this morning. The core read doubled expectations to +1.4% and ex-Transportation was still +0.9%. Non-defense, ex-Aircraft durables — ac proxy for general business spending — came in at +0.5%, the only lower figure in this set of numbers.

Best Buy Questions or comments about this article and/or its author? Click here>>

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes